These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7419682)

  • 1. Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.
    Crosignani PG; Ferrari C; Malinverni A; Barbieri C; Mattei AM; Caldara R; Rocchetti M
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1068-73. PubMed ID: 7419682
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
    Genazzani AR; De Leo V; Murru S; Cocchi D; Camanni F; Müller EE
    J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
    [No Abstract]   [Full Text] [Related]  

  • 3. Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
    Gonzalez-Villapando C; Szabo M; Frohman LA
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1417-24. PubMed ID: 7440704
    [No Abstract]   [Full Text] [Related]  

  • 4. Nomifensine: diagnostic test in hyperprolactinemic states.
    Müller EE; Genazzani AR; Murru S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomifensine in the diagnosis of hyperprolactinemia.
    Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
    Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME; Goodman RH; Post KD; Biller BJ; Moses AC; King LW; Feldman ZT; Reichlin S
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
    Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
    J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
    Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
    J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential diagnosis of hyperprolactinemia].
    Takeda R; Minagawa F; Nakabayashi H
    Nihon Rinsho; 1986 Mar; 44(3):671-7. PubMed ID: 2874247
    [No Abstract]   [Full Text] [Related]  

  • 18. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
    Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
    Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of CNS dopamine augmentation on stimulated prolactin secretion.
    Woolf PD; Leebaw WJ; Lee LA
    J Clin Endocrinol Metab; 1977 Oct; 45(4):857-60. PubMed ID: 410827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.